Epidemiology of H. Pylori Transmission
NCT02740140 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1750
Last updated 2016-04-15
Summary
This observational epidemiologic study with nested cross-sectional and longitudinal aims will evaluate host immune response to mixed chronic infections (Helicobacter pylori, latent tuberculosis, intestinal helminthiasis) in recent US immigrants.
Conditions
- Communicable Diseases
Sponsors & Collaborators
-
Santa Clara Valley Health & Hospital System
collaborator OTHER - lead OTHER
Principal Investigators
-
Julie Parsonnet · Stanford University
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2011-06-30
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
NCT05674032 ·Status: UNKNOWN
-
European Registry on the Management of Helicobacter Pylori Infection
NCT02328131 ·Status: RECRUITING
-
One Sequencing Find All for Helicobacter Pylori Infection
NCT03837990 ·Status: UNKNOWN
-
Concomitant Infection of Intestinal Parasites and Helicobacter Pylori
NCT05360940 ·Status: UNKNOWN
-
Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy
NCT05329636 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Antimicrobial Susceptibility for Helicobacter Pylori Eradication
NCT01486082 ·Status: UNKNOWN
-
Intestinal Flora and Metabonomics of Appendicitis
NCT06035029 ·Status: UNKNOWN
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms.
NCT03524014 ·Status: UNKNOWN
-
Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus
NCT02547272 ·Status: COMPLETED
-
Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes
NCT01300039 ·Status: COMPLETED
-
Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis
NCT06873308 ·Status: RECRUITING ·Phase: NA
-
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
NCT04764500 ·Status: ACTIVE_NOT_RECRUITING
-
INSPIRE Trial for Abdominal Infections
NCT05423743 ·Status: COMPLETED ·Phase: NA
-
Human Microbiota and Liver Transplant
NCT02223468 ·Status: COMPLETED
-
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
NCT04759001 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prevalence of Digestive Carriage of Integrons
NCT01985217 ·Status: COMPLETED
-
Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
NCT02127450 ·Status: COMPLETED
-
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pancreatitis - Microbiome As Predictor of Severity
NCT04777812 ·Status: COMPLETED ·Phase: NA
-
Implications of the Human Microbiota for Health and Disease
NCT04203303 ·Status: RECRUITING
-
Longitudinal and Cross-sectional Analysis of Pulmonary Microbiota in Lung Transplant Recipients Infected With Nocardia
NCT06594133 ·Status: COMPLETED
-
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
NCT00304330 ·Status: COMPLETED
-
Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria
NCT05516433 ·Status: RECRUITING
-
Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg
NCT04995965 ·Status: UNKNOWN